During the past decade, Centro Medico Austral conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Austral" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Medico Austral" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Metastatic Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Centro Medico Austral" in a lesser frequency.

Most popular intervention types in "Centro Medico Austral" are "Drug" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Bemarituzumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico Austral" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centro Medico Austral". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Medico Austral, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico Austral, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".